๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count

โœ Scribed by Dr. V. Hug; M. Keating; K. McCredie; J. Hester; G. P. Bodey; E. J. Freireich

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
571 KB
Volume
52
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

acute tumor lysis syndrome and treatment
acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide
โœ Robert D. McCroskey; Deane F. Mosher; Cory D. Spencer; Edward Prendergast; Walte ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 501 KB

Acute tumor lysis syndrome resulting from rapid neoplastic cell lysis after chemotherapy is an unusual event, generally seen in histologically aggressive lymphatic tumors. The authors saw four patients who developed acute tumor lysis syndrome when treated for advanced-stage, refractory chronic lymph

Treatment of patients with recurrent and
Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine : A pharmacologically based regimen
โœ David W. Sternberg; William Aird; Donna Neuberg; Lynn Thompson; Kimberly MacNeil ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB ๐Ÿ‘ 2 views

## BACKGROUND. Although chemotherapy can achieve a high rate of disease remission induction in patients with newly diagnosed acute myelogenous leukemia (AML), patients with recurrent or refractory AML generally have a poorer rate of response. This study assessed the utility of mitoxantrone and inte